| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.80e-06 | 18 | 113 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.79e-05 | 28 | 113 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.79e-05 | 70 | 113 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.56e-05 | 37 | 113 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | TCP1 ZNFX1 DNAH7 DNAH14 ABCB1 DHX9 ACSL3 ABCC8 RAD54B KIF28P DNAH6 DYNC1H1 | 1.87e-04 | 614 | 113 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.59e-04 | 118 | 113 | 5 | GO:0003774 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CFAP47 ARMC3 CLASP2 SRGAP2 CEP192 SYBU LYST DNAH7 DNAH14 AKAP4 DOCK7 KIF28P TXNDC9 DNAH6 TRIM37 DYNC1H1 CNTN2 CFAP46 | 1.53e-05 | 1058 | 112 | 18 | GO:0007017 |
| GeneOntologyCellularComponent | endolysosome membrane | 1.56e-04 | 20 | 111 | 3 | GO:0036020 | |
| GeneOntologyCellularComponent | dynein complex | 1.94e-04 | 54 | 111 | 4 | GO:0030286 | |
| MousePheno | hypopigmentation | 1.50e-05 | 53 | 83 | 5 | MP:0005408 | |
| MousePheno | diluted coat color | 3.78e-05 | 64 | 83 | 5 | MP:0000371 | |
| MousePheno | abnormal tail pigmentation | 8.11e-05 | 39 | 83 | 4 | MP:0005174 | |
| MousePheno | absent lens vesicle | 1.04e-04 | 3 | 83 | 2 | MP:0009725 | |
| MousePheno | decreased tail pigmentation | 1.54e-04 | 18 | 83 | 3 | MP:0011277 | |
| MousePheno | abnormal skin pigmentation | 1.65e-04 | 87 | 83 | 5 | MP:0002095 | |
| Domain | ARM-type_fold | DCAF1 IPO5 ARMC3 DOCK8 MROH2A TTI2 ZNFX1 CLASP2 ECPAS LYST PIK3R4 ELMO3 MROH6 FHOD1 CAB39L USP35 TAF6 | 1.04e-11 | 339 | 108 | 17 | IPR016024 |
| Domain | ARM-like | DCAF1 IPO5 ARMC3 DOCK8 MROH2A TTI2 CLASP2 ECPAS PIK3R4 ELMO3 MROH6 FHOD1 CAB39L USP35 TAF6 | 4.50e-11 | 270 | 108 | 15 | IPR011989 |
| Domain | - | DCAF1 IPO5 ARMC3 CLASP2 ECPAS PIK3R4 MROH6 FHOD1 CAB39L TAF6 | 6.45e-07 | 222 | 108 | 10 | 1.25.10.10 |
| Domain | Dynein_heavy_chain_D4_dom | 1.01e-06 | 14 | 108 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.01e-06 | 14 | 108 | 4 | IPR024743 | |
| Domain | MT | 1.01e-06 | 14 | 108 | 4 | PF12777 | |
| Domain | AAA_8 | 1.01e-06 | 14 | 108 | 4 | PF12780 | |
| Domain | DHC_fam | 1.37e-06 | 15 | 108 | 4 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.37e-06 | 15 | 108 | 4 | IPR004273 | |
| Domain | Dynein_heavy | 1.37e-06 | 15 | 108 | 4 | PF03028 | |
| Domain | HEAT_REPEAT | 5.29e-05 | 70 | 108 | 5 | PS50077 | |
| Domain | Dynein_heavy_dom-2 | 6.53e-05 | 14 | 108 | 3 | IPR013602 | |
| Domain | DHC_N2 | 6.53e-05 | 14 | 108 | 3 | PF08393 | |
| Domain | HEAT | 1.69e-04 | 48 | 108 | 4 | PF02985 | |
| Domain | Mab-21-like_1/2 | 3.28e-04 | 5 | 108 | 2 | IPR020950 | |
| Domain | HEAT | 3.53e-04 | 58 | 108 | 4 | IPR000357 | |
| Domain | DUF3398 | 4.89e-04 | 6 | 108 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 4.89e-04 | 6 | 108 | 2 | IPR021816 | |
| Domain | P-loop_NTPase | TPST2 NLRP12 ZNFX1 DNAH7 DNAH14 ABCB1 DHX9 DAP3 CIITA ABCC8 RAD54B DNAH6 DYNC1H1 | 1.22e-03 | 848 | 108 | 13 | IPR027417 |
| Domain | - | TPST2 NLRP12 ZNFX1 DNAH7 DNAH14 ABCB1 DHX9 DAP3 ABCC8 RAD54B DNAH6 DYNC1H1 | 1.26e-03 | 746 | 108 | 12 | 3.40.50.300 |
| Domain | AAA+_ATPase | 1.50e-03 | 144 | 108 | 5 | IPR003593 | |
| Domain | AAA | 1.50e-03 | 144 | 108 | 5 | SM00382 | |
| Domain | DOCK_C | 1.76e-03 | 11 | 108 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 1.76e-03 | 11 | 108 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.76e-03 | 11 | 108 | 2 | PS51651 | |
| Domain | DHR_1 | 1.76e-03 | 11 | 108 | 2 | PS51650 | |
| Domain | DOCK-C2 | 1.76e-03 | 11 | 108 | 2 | PF14429 | |
| Domain | DHR-2 | 1.76e-03 | 11 | 108 | 2 | IPR027357 | |
| Domain | DHR-2 | 1.76e-03 | 11 | 108 | 2 | PF06920 | |
| Domain | DOCK | 1.76e-03 | 11 | 108 | 2 | IPR026791 | |
| Domain | Mab-21_dom | 2.11e-03 | 12 | 108 | 2 | IPR024810 | |
| Domain | Mab-21 | 2.11e-03 | 12 | 108 | 2 | PF03281 | |
| Domain | Mab-21 | 2.11e-03 | 12 | 108 | 2 | SM01265 | |
| Domain | ATPase_dyneun-rel_AAA | 2.88e-03 | 14 | 108 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.88e-03 | 14 | 108 | 2 | PF07728 | |
| Domain | LRR_6 | 3.97e-03 | 55 | 108 | 3 | PF13516 | |
| Domain | Leu-rich_rpt | 4.92e-03 | 271 | 108 | 6 | IPR001611 | |
| Domain | RhoGAP | 5.55e-03 | 62 | 108 | 3 | SM00324 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.62e-05 | 94 | 81 | 6 | MM15598 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 9.70e-05 | 16 | 81 | 3 | MM15605 | |
| Pubmed | KIAA0930 DOCK8 CLASP2 SRGAP2 CEP192 ECPAS ACSL3 USP10 BRAF PI4KB DOCK7 TRIM37 | 2.90e-08 | 446 | 114 | 12 | 24255178 | |
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 21655271 | ||
| Pubmed | TCP1 RSL1D1 CLASP2 CEP192 DNAH7 DHX9 ARHGAP1 DENND6A PI4KB CYB5R3 DOCK7 TXNDC9 DYNC1H1 | 1.71e-06 | 777 | 114 | 13 | 35844135 | |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 3.27e-06 | 190 | 114 | 7 | 15161933 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TPST2 KIAA0930 TRIO HECTD4 CLASP2 SRGAP2 CEP192 STK32C LYST FAM20C KLHL25 PTPRF MROH6 PLA2G4B DYNC1H1 | 3.42e-06 | 1105 | 114 | 15 | 35748872 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CDO1 KIAA0930 RSL1D1 CLASP2 SRGAP2 ECPAS DHX9 PIK3R4 DAP3 RPL7L1 BRAF PI4KB RAD54B TONSL CAB39L DYNC1H1 | 4.66e-06 | 1284 | 114 | 16 | 17353931 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.89e-06 | 202 | 114 | 7 | 33005030 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIAA0930 TRIO CLASP2 SRGAP2 CEP192 STK32C LYST DNAH7 PIK3R4 BRAF SRGAP1 PI4KB DOCK7 | 5.21e-06 | 861 | 114 | 13 | 36931259 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | IPO5 MIS18BP1 TCP1 RSL1D1 AHCTF1 SYBU DHX9 ACSL3 ARHGAP1 DAP3 RPL7L1 DNAJC28 CYB5R3 SECISBP2 TXNDC9 CLUH MTRF1L | 7.71e-06 | 1496 | 114 | 17 | 32877691 |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 33984363 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 8643598 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 11857508 | ||
| Pubmed | The Male Abnormal Gene Family 21 (Mab21) Members Regulate Eye Development. | 1.07e-05 | 2 | 114 | 2 | 27558071 | |
| Pubmed | Genomic cloning and chromosomal localization of the mouse Mab21l2 locus. | 1.07e-05 | 2 | 114 | 2 | 10516425 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 14769796 | ||
| Pubmed | 1.22e-05 | 14 | 114 | 3 | 9373155 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IPO5 TRIO TCP1 RSL1D1 CLASP2 ECPAS DHX9 PIK3R4 ACSL3 DAP3 USP10 RPL7L1 CYB5R3 DOCK7 CLUH DYNC1H1 | 1.70e-05 | 1425 | 114 | 16 | 30948266 |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | KIAA0930 TPCN2 ZNF337 PLPP7 CLASP2 SLC4A3 TMEM11 SLC15A4 ABCC8 SGSM3 FLRT1 | 1.92e-05 | 697 | 114 | 11 | 28298427 |
| Pubmed | 2.22e-05 | 255 | 114 | 7 | 15324660 | ||
| Pubmed | IPO5 TCP1 RSL1D1 AHCTF1 ZNFX1 ECPAS DHX9 ACSL3 USP10 RPL7L1 DYNC1H1 | 2.31e-05 | 711 | 114 | 11 | 33022573 | |
| Pubmed | IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation. | 3.19e-05 | 3 | 114 | 2 | 24204280 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 17868034 | ||
| Pubmed | Bridging channel dendritic cells induce immunity to transfused red blood cells. | 3.19e-05 | 3 | 114 | 2 | 27185856 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 23776173 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 19137586 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 22454535 | ||
| Pubmed | Variation in Cilia Protein Genes and Progression of Lung Disease in Cystic Fibrosis. | 3.19e-05 | 3 | 114 | 2 | 29323929 | |
| Pubmed | STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency. | 4.26e-05 | 192 | 114 | 6 | 32176739 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CDO1 RSL1D1 ECPAS DHX9 ACSL3 USP10 BRAF FHOD1 TIMELESS TAF6 CLUH | 4.98e-05 | 774 | 114 | 11 | 15302935 |
| Pubmed | A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. | 6.13e-05 | 205 | 114 | 6 | 12040188 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 15242870 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 9177216 | ||
| Pubmed | A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum. | 6.36e-05 | 4 | 114 | 2 | 11536079 | |
| Pubmed | IPO5 TRIO TCP1 DOCK8 ZNFX1 CLASP2 SRGAP2 DHX9 PIK3R4 USP10 DOCK7 MAST1 DNAH6 DYNC1H1 CNTN2 | 6.95e-05 | 1431 | 114 | 15 | 37142655 | |
| Pubmed | IPO5 TRIO RSL1D1 HECTD4 ZNFX1 SRGAP2 SLC4A3 PIK3R4 ARHGAP1 MAST1 SGSM3 TAF6 TRIM37 DYNC1H1 | 8.23e-05 | 1285 | 114 | 14 | 35914814 | |
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 39056782 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 13943454 | ||
| Pubmed | Autophagic elimination of ribosomes during spermiogenesis provides energy for flagellar motility. | 1.06e-04 | 5 | 114 | 2 | 34428398 | |
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 29196450 | ||
| Pubmed | MAB21L1 modulates gene expression and DNA metabolic processes in the lens placode. | 1.06e-04 | 5 | 114 | 2 | 34779479 | |
| Pubmed | An Anti-Inflammatory Role for NLRP10 in Murine Cutaneous Leishmaniasis. | 1.06e-04 | 5 | 114 | 2 | 28931602 | |
| Pubmed | 1.17e-04 | 332 | 114 | 7 | 37433992 | ||
| Pubmed | 1.45e-04 | 151 | 114 | 5 | 17043677 | ||
| Pubmed | SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance. | 1.58e-04 | 6 | 114 | 2 | 33514561 | |
| Pubmed | An evolutionarily conserved nested gene pair - Mab21 and Lrba/Nbea in metazoan. | 1.58e-04 | 6 | 114 | 2 | 19482073 | |
| Pubmed | 1.58e-04 | 6 | 114 | 2 | 12736724 | ||
| Pubmed | 1.58e-04 | 6 | 114 | 2 | 11672528 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 TCP1 TTI2 ECPAS DNAH14 DHX9 FAM20C DENND6A TAS2R31 DYNC1H1 | 1.60e-04 | 736 | 114 | 10 | 29676528 |
| Pubmed | Web-based, participant-driven studies yield novel genetic associations for common traits. | 1.91e-04 | 34 | 114 | 3 | 20585627 | |
| Pubmed | Polymorphisms in NACHT-LRR (NLR) genes in atopic dermatitis. | 2.21e-04 | 7 | 114 | 2 | 17620097 | |
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 17247190 | ||
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 10556287 | ||
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 2.43e-04 | 264 | 114 | 6 | 32814769 | |
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 19710684 | ||
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 18483556 | ||
| Pubmed | Chromosomal location of the murine anion exchanger genes encoding AE2 and AE3. | 2.94e-04 | 8 | 114 | 2 | 7894173 | |
| Pubmed | 3.11e-04 | 390 | 114 | 7 | 17643375 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | IPO5 TCP1 RSL1D1 ZNFX1 SRFBP1 DHX9 DAP3 USP10 RPL7L1 DYNC1H1 | 3.33e-04 | 807 | 114 | 10 | 22681889 |
| Pubmed | 3.78e-04 | 9 | 114 | 2 | 102659 | ||
| Pubmed | The fine structure of melanogenesis in coat color mutants of the mouse. | 3.78e-04 | 9 | 114 | 2 | 4634048 | |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 3.91e-04 | 104 | 114 | 4 | 36055981 | |
| Pubmed | IPO5 DOCK8 IRF4 CLASP2 ECPAS DHX9 PIK3R4 ACSL3 FHOD1 CYB5R3 DYNC1H1 FERMT3 | 4.62e-04 | 1168 | 114 | 12 | 19946888 | |
| Pubmed | 4.71e-04 | 10 | 114 | 2 | 31231033 | ||
| Pubmed | Genetic determinants of hair, eye and skin pigmentation in Europeans. | 4.71e-04 | 10 | 114 | 2 | 17952075 | |
| Pubmed | 5.01e-04 | 47 | 114 | 3 | 8812413 | ||
| Pubmed | 5.19e-04 | 425 | 114 | 7 | 21081503 | ||
| Pubmed | 5.54e-04 | 708 | 114 | 9 | 39231216 | ||
| Pubmed | 5.66e-04 | 49 | 114 | 3 | 17567985 | ||
| Pubmed | Two new cataract loci, Ccw and To3, and further mapping of the Npp and Opj cataracts in the mouse. | 5.75e-04 | 11 | 114 | 2 | 8812411 | |
| Pubmed | Nudel binds Cdc42GAP to modulate Cdc42 activity at the leading edge of migrating cells. | 5.75e-04 | 11 | 114 | 2 | 18331715 | |
| Pubmed | Genome-wide association study of tanning phenotype in a population of European ancestry. | 5.75e-04 | 11 | 114 | 2 | 19340012 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | DCAF1 IPO5 MIS18BP1 AHCTF1 DHX9 ACSL3 PTPRF FHOD1 CYB5R3 DOCK7 TIMELESS CLUH | 5.99e-04 | 1203 | 114 | 12 | 29180619 |
| Pubmed | 6.12e-04 | 437 | 114 | 7 | 20562859 | ||
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 6.30e-04 | 118 | 114 | 4 | 27377895 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 6.83e-04 | 582 | 114 | 8 | 20467437 | |
| Pubmed | The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. | 6.88e-04 | 12 | 114 | 2 | 12379855 | |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 7.64e-04 | 217 | 114 | 5 | 31685992 | |
| Pubmed | 8.11e-04 | 13 | 114 | 2 | 15938754 | ||
| Pubmed | 8.11e-04 | 13 | 114 | 2 | 28137874 | ||
| Pubmed | Identification and characterization of human taste receptor genes belonging to the TAS2R family. | 8.11e-04 | 13 | 114 | 2 | 12584440 | |
| Pubmed | 8.11e-04 | 13 | 114 | 2 | 30254148 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 8.26e-04 | 333 | 114 | 6 | 32665550 | |
| Pubmed | 8.41e-04 | 601 | 114 | 8 | 33658012 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TCP1 RSL1D1 AHCTF1 DHX9 ARHGAP1 DAP3 USP10 RPL7L1 SRGAP1 FHOD1 DOCK7 DYNC1H1 | 8.78e-04 | 1257 | 114 | 12 | 36526897 |
| Pubmed | 9.16e-04 | 226 | 114 | 5 | 31452512 | ||
| Pubmed | Cell-autonomous involvement of Mab21l1 is essential for lens placode development. | 9.45e-04 | 14 | 114 | 2 | 12642482 | |
| Pubmed | 9.45e-04 | 14 | 114 | 2 | 17903295 | ||
| Pubmed | 9.45e-04 | 14 | 114 | 2 | 12432077 | ||
| Pubmed | 1.05e-03 | 233 | 114 | 5 | 37704626 | ||
| Pubmed | Interaction of the murine dilute suppressor gene (dsu) with fourteen coat color mutations. | 1.09e-03 | 15 | 114 | 2 | 2379821 | |
| Pubmed | 1.09e-03 | 15 | 114 | 2 | 23548203 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.13e-03 | 486 | 114 | 7 | 30940648 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | IPO5 TCP1 RSL1D1 AHCTF1 DHX9 USP10 RPL7L1 DOCK7 TAF6 DYNC1H1 | 1.15e-03 | 949 | 114 | 10 | 36574265 |
| Pubmed | DCAF1 RSL1D1 AHCTF1 CLASP2 CEP192 DHX9 ACSL3 ARHGAP1 DAP3 USP10 RPL7L1 DNAJC28 CLUH | 1.19e-03 | 1487 | 114 | 13 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TPCN2 TRIO HECTD4 CLASP2 SRGAP2 CEP192 STK32C ECPAS DNAH14 USP10 ABCC8 MAST1 CAB39L | 1.21e-03 | 1489 | 114 | 13 | 28611215 |
| Pubmed | 1.22e-03 | 241 | 114 | 5 | 23125841 | ||
| Pubmed | 1.24e-03 | 16 | 114 | 2 | 29764992 | ||
| Pubmed | Human chromosome 19 and related regions in mouse: conservative and lineage-specific evolution. | 1.24e-03 | 16 | 114 | 2 | 11441184 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 1.24e-03 | 639 | 114 | 8 | 23443559 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.31e-03 | 498 | 114 | 7 | 36634849 | |
| GeneFamily | Dyneins, axonemal | 3.48e-05 | 17 | 69 | 3 | 536 | |
| GeneFamily | Maestro heat like repeat containing | 7.72e-04 | 11 | 69 | 2 | 636 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 9.17e-04 | 50 | 69 | 3 | 721 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1 | KIAA0930 TRIO IRF4 STK32C ZNF496 LYST ABCB1 CIITA SLC15A4 DOCK7 | 2.17e-05 | 382 | 106 | 10 | GSM538248_500 |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.69e-07 | 193 | 114 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 7.42e-07 | 196 | 114 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.56e-06 | 151 | 114 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.18e-06 | 176 | 114 | 6 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.18e-06 | 176 | 114 | 6 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.60e-06 | 178 | 114 | 6 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.26e-06 | 181 | 114 | 6 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.26e-06 | 181 | 114 | 6 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.49e-06 | 182 | 114 | 6 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 7.49e-06 | 182 | 114 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.97e-06 | 184 | 114 | 6 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.22e-06 | 185 | 114 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.22e-06 | 185 | 114 | 6 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 8.22e-06 | 185 | 114 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.48e-06 | 186 | 114 | 6 | 708c5edefe36c91df27cf53c1b5101fb2030cc5a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.48e-06 | 186 | 114 | 6 | 029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.74e-06 | 187 | 114 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 9.01e-06 | 188 | 114 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.01e-06 | 188 | 114 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.01e-06 | 188 | 114 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.29e-06 | 189 | 114 | 6 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.29e-06 | 189 | 114 | 6 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.29e-06 | 189 | 114 | 6 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 9.29e-06 | 189 | 114 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 9.29e-06 | 189 | 114 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.86e-06 | 191 | 114 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.86e-06 | 191 | 114 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.86e-06 | 191 | 114 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.02e-05 | 192 | 114 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.02e-05 | 192 | 114 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 1.02e-05 | 192 | 114 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.08e-05 | 194 | 114 | 6 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.08e-05 | 194 | 114 | 6 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.25e-05 | 199 | 114 | 6 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.25e-05 | 199 | 114 | 6 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.28e-05 | 200 | 114 | 6 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.28e-05 | 200 | 114 | 6 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.28e-05 | 200 | 114 | 6 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-05 | 200 | 114 | 6 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.96e-05 | 148 | 114 | 5 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.96e-05 | 148 | 114 | 5 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.36e-05 | 76 | 114 | 4 | f653a09d6707d9b34db4ef486212aeba5610f47b | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.36e-05 | 76 | 114 | 4 | 47deea63d975366a42834c22cc163c4c7142d51d | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.36e-05 | 76 | 114 | 4 | 079e1af894e670f63d718e16599f20d920643160 | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.36e-05 | 151 | 114 | 5 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-05 | 154 | 114 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-05 | 154 | 114 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.94e-05 | 155 | 114 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.94e-05 | 155 | 114 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 157 | 114 | 5 | 8d30d8e6fae93afcada6bd68799439335cd65b69 | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 157 | 114 | 5 | 2ac4695d9e4ca8d4ba19c555e9a1d86ac8f398ab | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 157 | 114 | 5 | 8a393eece90fb9a1b7c356736bdb36277261fbd3 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.74e-05 | 160 | 114 | 5 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.74e-05 | 160 | 114 | 5 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.45e-05 | 164 | 114 | 5 | d9531848105d606adedde65426177cf851140e31 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.64e-05 | 165 | 114 | 5 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.64e-05 | 165 | 114 | 5 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 165 | 114 | 5 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.43e-05 | 169 | 114 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 169 | 114 | 5 | 149a4f83da15bdeb170e980fb5b5b1af89ae07a6 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.24e-05 | 177 | 114 | 5 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.75e-05 | 179 | 114 | 5 | ce95b601bf17ae8167d382a105384b9e65e9407f | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.00e-04 | 180 | 114 | 5 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-04 | 182 | 114 | 5 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-04 | 185 | 114 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.14e-04 | 185 | 114 | 5 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-04 | 186 | 114 | 5 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.17e-04 | 186 | 114 | 5 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 1.20e-04 | 187 | 114 | 5 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 187 | 114 | 5 | e61992de4f98eeea08b43213850769d923f8db48 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 1.23e-04 | 188 | 114 | 5 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.26e-04 | 189 | 114 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.32e-04 | 191 | 114 | 5 | 3a5081dc542ac6262acfe5f8084a86616fee8082 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-04 | 191 | 114 | 5 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 1.32e-04 | 191 | 114 | 5 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-04 | 191 | 114 | 5 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 1.32e-04 | 191 | 114 | 5 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.39e-04 | 193 | 114 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.39e-04 | 193 | 114 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 193 | 114 | 5 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 1.42e-04 | 194 | 114 | 5 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-04 | 194 | 114 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-04 | 194 | 114 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 1.42e-04 | 194 | 114 | 5 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.45e-04 | 195 | 114 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 195 | 114 | 5 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.45e-04 | 195 | 114 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 195 | 114 | 5 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.45e-04 | 195 | 114 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.49e-04 | 196 | 114 | 5 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.49e-04 | 196 | 114 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-04 | 196 | 114 | 5 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.49e-04 | 196 | 114 | 5 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-04 | 196 | 114 | 5 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.49e-04 | 196 | 114 | 5 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.49e-04 | 196 | 114 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| Disease | pigmentation disease (is_implicated_in) | 7.92e-06 | 11 | 109 | 3 | DOID:10123 (is_implicated_in) | |
| Disease | protein MRVI1 measurement | 4.05e-05 | 3 | 109 | 2 | EFO_0801953 | |
| Disease | suntan, skin pigmentation | 8.07e-05 | 4 | 109 | 2 | EFO_0003784, EFO_0004279 | |
| Disease | protein-tyrosine sulfotransferase 2 measurement | 3.73e-04 | 8 | 109 | 2 | EFO_0801971 | |
| Disease | sunburn | 4.51e-04 | 96 | 109 | 4 | EFO_0003958 | |
| Disease | Colon Carcinoma | 4.79e-04 | 9 | 109 | 2 | C0699790 | |
| Disease | suntan | 5.88e-04 | 103 | 109 | 4 | EFO_0004279 | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 5.97e-04 | 10 | 109 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 5.97e-04 | 10 | 109 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | hyperinsulinism (is_implicated_in) | 8.71e-04 | 12 | 109 | 2 | DOID:2018 (is_implicated_in) | |
| Disease | interleukin 1 receptor antagonist measurement | 1.00e-03 | 53 | 109 | 3 | EFO_0004754 | |
| Disease | Peripheral Nervous System Diseases | 1.06e-03 | 54 | 109 | 3 | C4721453 | |
| Disease | hair color | 1.07e-03 | 311 | 109 | 6 | EFO_0003924 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 1.38e-03 | 15 | 109 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | non-lobar intracerebral hemorrhage | 1.66e-03 | 63 | 109 | 3 | EFO_0010178 | |
| Disease | squamous cell carcinoma | 1.98e-03 | 67 | 109 | 3 | EFO_0000707 | |
| Disease | nevus count | 1.99e-03 | 18 | 109 | 2 | EFO_0004632 | |
| Disease | Adrenocortical carcinoma | 1.99e-03 | 18 | 109 | 2 | C0206686 | |
| Disease | renal cell carcinoma (is_implicated_in) | 2.15e-03 | 69 | 109 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | skin sensitivity to sun | 2.22e-03 | 19 | 109 | 2 | EFO_0004795 | |
| Disease | cerebral microbleeds | 2.22e-03 | 19 | 109 | 2 | EFO_0010059 | |
| Disease | Lymphoma, Non-Hodgkin, Familial | 2.98e-03 | 22 | 109 | 2 | C4721532 | |
| Disease | Granulomatous Slack Skin | 2.98e-03 | 22 | 109 | 2 | C0376407 | |
| Disease | epilepsy (implicated_via_orthology) | 3.18e-03 | 163 | 109 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Lymphoma, T-Cell, Cutaneous | 3.25e-03 | 23 | 109 | 2 | C0079773 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRECIRHEPLAKIIL | 146 | Q9H9S4 | |
| LASIELLARSLPKIH | 711 | P15056 | |
| PEDRASVLRTLLLKH | 411 | P48751 | |
| IPASVVLKRVLLRHT | 361 | Q5JQC9 | |
| HILKRPDRVLLILDG | 486 | P33076 | |
| DILQKLLRRVPHLLT | 531 | Q8NB90 | |
| LLRRVPHLLTEAELL | 536 | Q8NB90 | |
| KIVLVADRHLLELPL | 2326 | Q8IYW2 | |
| LLQLHRPVLRKIEEV | 226 | Q8TAV3 | |
| IIRHRPALVKVILIS | 91 | Q8NEA5 | |
| PLTKLLTHEDKIVRR | 71 | Q5W041 | |
| LDLRIRPHVLLKVLQ | 486 | Q8IWA6 | |
| VLSKLLAVIHELRPT | 646 | Q9Y620 | |
| VRRLLLGKVLALEHL | 571 | Q04671 | |
| ILLRPELEELRNKHS | 216 | P00387 | |
| IARALVRQPHILLLD | 1186 | P08183 | |
| AIVAKRPHELLNRLI | 436 | Q7RTS5 | |
| PEKELLLLIRNHLIS | 846 | Q9Y4B6 | |
| KIVLATPRLHITIPR | 341 | Q6P0N0 | |
| RQRKLITAHVEPLLA | 396 | Q15306 | |
| LKELRLEDNLLTHLP | 446 | A6NIV6 | |
| LHKALLRRGIVELLL | 241 | Q8NCI6 | |
| LHRILTDILEVRQKP | 386 | Q6ICG6 | |
| RKSLRKLEPELHLIS | 316 | P08254 | |
| TRVKLKIVPHLLRSR | 331 | Q5VYK3 | |
| DVLLRKLRVHRSLPG | 501 | Q9Y6F6 | |
| LLIFIILTKRSLHEP | 46 | Q8NGK2 | |
| ILRSHLIKATVIPNR | 11 | Q9NX36 | |
| KLVLQSLVPLLLRLH | 526 | A6NGR9 | |
| LLTVRVLQAHRLPSK | 11 | P0C869 | |
| LTLLIILRHLTRKDP | 2936 | Q9Y4D8 | |
| LRPHLEATLQLSLKL | 251 | O00410 | |
| RSLPALTNIIKILRH | 86 | P00439 | |
| KKLLIIISRPARLLE | 276 | Q9Y2H9 | |
| LLLIDTRLLREKLIP | 671 | Q9C0G6 | |
| EPKETLREVLHLLRS | 516 | A0AVF1 | |
| KVHLPELLRSVRLAL | 226 | Q9H0H3 | |
| VRFLHLLLDKLILLV | 786 | Q96N67 | |
| IPILEAHREFRKLTL | 1756 | Q8NF50 | |
| PHLEALDRRLRVVLK | 541 | Q8IXL6 | |
| VLKPRTLADLIRILH | 6 | Q16878 | |
| IPISDLILKRRLIHG | 136 | Q96SL1 | |
| ISRILKQPRSHALLV | 2326 | Q8WXX0 | |
| RLRTVHPILLALILS | 516 | Q7Z388 | |
| EKLRTHIDAIILALP | 581 | Q8IWF6 | |
| RRKPHLLLVAAVALV | 6 | Q02246 | |
| LVKSEVPLDRLLVHL | 206 | Q96BJ8 | |
| VRRILEKALTLLPIA | 1436 | Q0VDD8 | |
| LPILLKSRVIRDLFL | 781 | Q99698 | |
| LSVLKTLRDRHLELP | 251 | Q9Y586 | |
| KLINRTHATVPIRLI | 1521 | Q8TEP8 | |
| PPLRRRKLEHLITEL | 1801 | Q14204 | |
| GKILPRVHRKLAIER | 1001 | Q8WYP5 | |
| LPKRIHLRAEALPLA | 4896 | Q8NDH2 | |
| RDSLARIPLLEKLHL | 116 | Q9NZU1 | |
| LAKHELAPALRARLT | 916 | Q9Y613 | |
| IPLKDKLVDPILRRH | 381 | Q8N697 | |
| VAHLGRTKVLLLQPR | 946 | Q6ZTR5 | |
| LKPAVVERLHLALRR | 701 | Q5SV97 | |
| PITTRTKLQHLDRLI | 456 | B7ZC32 | |
| TPLHEIALSIKLLRL | 796 | Q08211 | |
| LIVIAILLFKRKRTH | 1276 | P10586 | |
| IILTVLVDIRLHRPM | 66 | Q8NH81 | |
| RLRVLLGRPAHEKLL | 246 | Q6PHW0 | |
| HPEVRRLLIDGILLL | 1136 | A6NES4 | |
| VPKERLALLHKDTRL | 66 | Q504T8 | |
| ITRLISRIHKLDPGR | 6 | P51398 | |
| LIFLHLKRRVKSVIL | 116 | P59538 | |
| LIFLHLKRRVKSVVL | 116 | P59540 | |
| LRLKPRSIHELSVEQ | 206 | P49848 | |
| PLILIHLLDLKDRSS | 616 | O94972 | |
| ERALHIRKLLLTLPR | 611 | Q7Z6B7 | |
| LSILKTLRDRHLELP | 251 | Q13394 | |
| VRLRRLEVKPHALEL | 76 | Q6DKI1 | |
| HLKVRRPELLAVIKL | 56 | Q9UGC7 | |
| LHLPAVILKTFLREL | 311 | Q07960 | |
| LRHLIVQYLPRLDKL | 251 | Q96HU1 | |
| RRLVLGLREVLKHLK | 671 | Q96T21 | |
| AITILRIDDLIKLHP | 521 | P17987 | |
| IRLPLRLINISHLIR | 81 | Q96LA9 | |
| LRKLILSDELKPAHR | 236 | Q9UBF8 | |
| VALLRKLLTVNPEHR | 326 | Q86UX6 | |
| KLPLHTLRSRLSIIL | 1411 | Q09428 | |
| LKDIVSLVPRLRHII | 221 | O95573 | |
| EVRTKLRIHLLAALI | 186 | Q8NBQ7 | |
| PTIRALALKVLREIL | 1116 | O75122 | |
| LALKVLREILRHQPA | 1121 | O75122 | |
| LERTSRPLKILRHQV | 521 | O75153 | |
| KVLELVLRSPARHQL | 791 | O75153 | |
| LILHLAPRLSVEILL | 401 | Q99570 | |
| IERILLLVRNILHVP | 156 | Q9UNS1 | |
| LTRLDLSLNRLKHIP | 641 | Q9NR97 | |
| LVLHPRRSLKLILDF | 241 | O60704 | |
| EAVRPALILILKRLD | 2576 | Q8N2C7 | |
| PVVLVRKDDLHRKRL | 156 | P17152 | |
| LLHRAVIVVLPLSLV | 91 | A6NFC5 | |
| KELRVRLTLPHSIRS | 76 | O76021 | |
| LTVRHLKRLERVIIG | 376 | Q6NXR4 | |
| TERAIARLAVHPLLK | 96 | Q8NEF9 | |
| HDKEISRSRIPRLIL | 16 | Q9NX95 | |
| PLLRALKLHTALREL | 1061 | Q96HA7 | |
| RKILDDVSIPLLLRL | 821 | Q9P2H5 | |
| LRPELHTKEQILELL | 71 | Q6NSZ9 | |
| PRDTKLIHAILVRLS | 466 | O94964 | |
| ERALHIRKVLLVLPK | 596 | O75044 | |
| LTTIPELKDHLRIFR | 346 | Q86UX7 | |
| RLELVKLSRKHPELI | 316 | Q6UW63 | |
| LLKLRPRKDLVETLL | 96 | Q9H040 | |
| ALLERKSLLHQLLPE | 1666 | Q9P2E3 | |
| LRPERHTKEQILELL | 71 | Q96IT1 | |
| RRVTLEKLPPVLVLH | 671 | Q14694 | |
| ERLHIKVIPTLALLK | 136 | O14530 | |
| LALLRQVLKSEDPRH | 231 | Q5TAA0 | |
| LSLVCHEPLRIRRLL | 176 | Q8NHX9 | |
| RLGHRLQLTDLLIKP | 2086 | O75962 | |
| SHLVLAVPLRVLLVL | 206 | Q8NBV4 | |
| LGILHSKPELIRRLE | 51 | Q9Y3M9 | |
| NKLAVLPRLRSLTLH | 121 | Q96E66 | |
| TTRPTALEKLHRLLE | 341 | P59046 | |
| AHLRLCLERLKVLIP | 81 | P50539 |